The World Health Organization has issued a warning against the use of two Indian children’s cough syrups after Uzbekistan fatalities were connected to them.
The Marion Biotech-produced goods, according to WHO, were “substandard,” and the company had failed to provide assurances regarding their safety.
The warning was issued a few weeks after Uzbekistan claimed that 18 kids had perished after ingesting a syrup produced by the business.
The business has not yet responded to the warning.
The health ministry of India and Marion Biotech have both been approached by the BBC for comment.
The manufacturing at the firm was halted by India’s health government after the fatalities were made public in Uzbekistan.
The company’s manufacturing license was also halted this week by the food safety division of Uttar Pradesh, a state in northern India that is home to Marion Biotech.
An investigation of the two cough syrups, Ambronol and Dok-1 Max, conducted by the quality control labs of the Uzbekistani health ministry revealed prohibited levels of two pollutants, “diethylene glycol and/or ethylene glycol,” according to the WHO notice released on Thursday.
Humans are poisonous to diethylene glycol and ethylene glycol, which means ingestion might be lethal.
“There may be marketing permits for each of these items in other regional nations. Additionally, they could have been supplied through unofficial markets to other nations or areas “WHO said.
They were “unsafe and their usage, particularly in minors, may result in severe harm or death,” it said.
India, which supplies a third of the world’s medications and much of the medical requirements of poor nations, is referred to as the “world’s pharmacy.” Some of the pharmaceutical businesses with the quickest growth rates are based in this nation.
However, because cough syrups produced by Indian corporations have been connected to child fatalities in other nations, the sector has come under heightened scrutiny.
The WHO had issued a similar warning in October, attributing 66 children’s deaths in The Gambia from kidney injury to four cough syrups produced by another Indian company.
The charges have been refuted by the Indian government as well as Maiden Pharmaceuticals.